iNtRON Biotechnology Inc (048530) — Cash Flow Reinvestment Rate
iNtRON Biotechnology Inc (048530) has a Cash Flow Reinvestment Rate of 0.88x as of March 2025, reinvesting ₩1.70 Billion (capex ₩321.62 Million plus investments ₩1.38 Billion) from operating cash flow of ₩1.94 Billion. Explore iNtRON Biotechnology Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
iNtRON Biotechnology Inc Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for iNtRON Biotechnology Inc across 6 annual periods. Also explore 048530 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for iNtRON Biotechnology Inc (2015–2023)
Year-by-year capital reinvestment analysis for iNtRON Biotechnology Inc. For live market cap and broader valuation context, see iNtRON Biotechnology Inc (048530) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 19.79x | ₩61.70 Billion | ₩3.12 Billion | ₩9.55 Billion | ▲ +157.7% |
| 2022 | 7.68x | ₩45.90 Billion | ₩5.98 Billion | ₩2.23 Billion | ▲ +207.6% |
| 2021 | 2.50x | ₩41.13 Billion | ₩16.47 Billion | ₩3.05 Billion | ▲ +38.5% |
| 2020 | 1.80x | ₩12.86 Billion | ₩7.13 Billion | ₩4.85 Billion | ▲ +634.2% |
| 2018 | 0.25x | ₩1.03 Billion | ₩4.20 Billion | ₩550.58 Million | ▼ -95.3% |
| 2015 | 5.19x | ₩8.83 Billion | ₩1.70 Billion | ₩6.30 Billion | — |